+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
From
KPL-716 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KPL-716 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
Red Biotechnology Market Report and Forecast 2024-2032 - Product Thumbnail Image

Red Biotechnology Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 172 Pages
  • Global
From
From
From
Leukemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Leukemia Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
From
HPV Associated Disorders Global Market Report 2024 - Product Thumbnail Image

HPV Associated Disorders Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
Targeted Oncology Therapeutics: Breast Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Breast Cancers

  • Report
  • October 2021
  • 68 Pages
  • Global
From
From
Loading Indicator